Elevance Health
Pelican Bay believes Elevance is recovering from weakness in the Medicare insurance market as management reprices plans to account for higher medical costs. The company is also…
ELV
5 published ideas on Elevance Health across 5 funds — 5 long and 0 short.
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Elevance Health: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Pelican Bay believes Elevance is recovering from weakness in the Medicare insurance market as management reprices plans to account for higher medical costs. The company is also…
Elevance Health rallied as margins recovered after a prolonged decline. First Eagle attributes the improvement to declining medical costs, stronger pricing and increased…
Elevance is part of Eagle's 13% managed-care allocation. The industry combines significant scale advantages with structural growth above the broader economy, but recent cost and…
Hotchkis & Wiley sees increasing evidence that Elevance's profitability is recovering. Despite the share-price improvement, the company remains valued at a discount to the…
Sound Shore identified Elevance after the stock sold off on concerns about regulatory risk and weak margins in Medicaid and Medicare. At roughly 13 times earnings with…